AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 160 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $18,368,007 | +23.3% | 782,950 | +32.7% | 0.00% | 0.0% |
| Q1 2024 | $14,899,662 | +3.9% | 589,852 | -3.8% | 0.00% | 0.0% |
| Q4 2023 | $14,339,402 | -54.1% | 613,275 | +85.2% | 0.00% | -57.1% |
| Q3 2023 | $31,236,268 | +220.0% | 331,085 | +58.4% | 0.01% | +250.0% |
| Q2 2023 | $9,760,218 | +14.2% | 209,043 | -6.4% | 0.00% | 0.0% |
| Q1 2023 | $8,543,113 | -16.1% | 223,291 | +20.1% | 0.00% | 0.0% |
| Q4 2022 | $10,187,977 | +14021.5% | 185,912 | -91.2% | 0.00% | -88.9% |
| Q3 2022 | $72,145 | – | 2,118,797 | +13.7% | 0.02% | – |
| Q2 2022 | $0 | -100.0% | 1,863,604 | +70.6% | 0.00% | -100.0% |
| Q1 2022 | $15,505,000 | -58.5% | 1,092,680 | -38.2% | 0.00% | -57.1% |
| Q4 2021 | $37,366,000 | +5261.0% | 1,766,714 | +5565.5% | 0.01% | – |
| Q3 2021 | $697,000 | -1.7% | 31,184 | +9.1% | 0.00% | – |
| Q2 2021 | $709,000 | -88.3% | 28,574 | -86.4% | 0.00% | -100.0% |
| Q1 2021 | $6,076,000 | -9.3% | 209,427 | -19.4% | 0.00% | 0.0% |
| Q4 2020 | $6,700,000 | +203.2% | 259,705 | +261.9% | 0.00% | +100.0% |
| Q3 2020 | $2,210,000 | +25.3% | 71,758 | +1.4% | 0.00% | 0.0% |
| Q2 2020 | $1,764,000 | +52.2% | 70,771 | +29.5% | 0.00% | – |
| Q1 2020 | $1,159,000 | +41.5% | 54,663 | +48.2% | 0.00% | – |
| Q4 2019 | $819,000 | +37.9% | 36,886 | +41.2% | 0.00% | – |
| Q3 2019 | $594,000 | -46.7% | 26,124 | -55.1% | 0.00% | – |
| Q2 2019 | $1,114,000 | – | 58,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |